Comparison between Gaudium IVF IPO and Prostarm Info Systems IPO.
Gaudium IVF IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Prostarm Info Systems IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Gaudium IVF IPO is up to ₹165.00 Cr whereas the issue size of the Prostarm Info Systems IPO is up to ₹168.00 Cr. The final issue price of Gaudium IVF IPO is ₹79.00 per share and of Prostarm Info Systems IPO is ₹105.00 per share.
| Gaudium IVF IPO | Prostarm Info Systems IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ₹75.00 per share | ₹95.00 per share |
| Issue Price (Upper) | ₹79.00 per share | ₹105.00 per share |
| Issue Price (Final) | ₹79.00 per share | ₹105.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 189 shares | 142 shares |
| Fresh Issue Size | 1,13,92,500 shares | 1,60,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹90.00 Cr | up to ₹168.00 Cr |
| OFS Issue Size | 94,93,700 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹75.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,08,86,200 shares | 1,60,00,000 shares |
| Issue Size Total (Amount) | up to ₹165.00 Cr | up to ₹168.00 Cr |
Gaudium IVF IPO opens on Feb 20, 2026, while Prostarm Info Systems IPO opens on May 27, 2025. The closing date of Gaudium IVF IPO and Prostarm Info Systems IPO is Feb 24, 2026, and May 29, 2025, respectively.
| Gaudium IVF IPO | Prostarm Info Systems IPO | |
|---|---|---|
| Anchor Bid Date | Feb 19, 2026 | May 26, 2025 |
| Issue Open | Feb 20, 2026 | May 27, 2025 |
| Issue Close | Feb 24, 2026 | May 29, 2025 |
| Basis Of Allotment (Tentative) | Feb 25, 2026 | May 30, 2025 |
| Initiation of Refunds (Tentative) | Feb 25, 2026 | Jun 02, 2025 |
| Credit of Share (Tentative) | Feb 26, 2026 | Jun 02, 2025 |
| Listing date (Tentative) | Feb 27, 2026 | Jun 03, 2025 |
| Anchor Lockin End date 1 | Mar 26, 2026 | Jun 28, 2025 |
| Anchor Lockin End date 2 | May 25, 2026 | Aug 28, 2025 |
Gaudium IVF IPO P/E ratio is 25.36, as compared to Prostarm Info Systems IPO P/E ratio of 19.75.
| Gaudium IVF IPO | Prostarm Info Systems IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.30 | 72.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 25.36 | 19.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹575.02 Cr. | ₹618.18 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 41.31% | 31.41% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 39.70% | 32.41% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.41 | 0.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.12 | ₹5.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 41.71% | 32.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Gaudium IVF IPO Retail Individual Investors (RII) are offered 73,10,170 shares while in Prostarm Info Systems IPO retail investors are offered 73,10,170 shares. Qualified Institutional Buyers (QIB) are offered 41,77,240 shares in Gaudium IVF IPO and 32,00,000 shares in Prostarm Info Systems IPO.
| Gaudium IVF IPO | Prostarm Info Systems IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,65,860 shares | 48,00,000 shares |
| Market Maker Reservation | 0 shares | |
| QIB | 41,77,240 shares | 32,00,000 shares |
| NII | 31,32,930 shares | 24,00,000 shares |
| RII | 73,10,170 shares | 56,00,000 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 2,08,86,200 shares | 1,60,00,000 shares |
Gaudium IVF IPO subscribed 7.27x in total, whereas Prostarm Info Systems IPO subscribed 96.68x.
| Gaudium IVF IPO | Prostarm Info Systems IPO | |
|---|---|---|
| QIB (times) | 1.62x | 102.67x |
| NII (times) | 14.05x | 222.13x |
| Big NII (times) | 12.71x | 249.80x |
| Small NII (times) | 16.73x | 166.78x |
| RII (times) | 7.60x | 39.48x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 7.27x | 96.68x |
